Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Canada Research Chairs

University of Guelph

$120,000.00

Microbial Functional Genomics and Synthetic Biology

FY 2024-25

Summary
Studying the genetic underpinnings of fungal biology and drug resistance has been hindered by genetic limitations associated working with this group of microbes, including its diploid nature, incomplete sexual cycle and atypical codon usage. CRISPR-Cas-based technologies have now revolutionized our ability to perform targeted genome editing in these microorganisms. This CRC research program will develop novel CRISPR-based biotechnologies to establish large-scale genetic libraries for functional analysis in the prevalent fungal pathogen, Candida albicans. Like other fungal infections, C. albicans is notoriously challenging to treat and represents a growing public health concern. This research will exploit a novel CRISPR interference (CRISPRi)-based genetic repression system for comparative functional genomic analysis of drug resistance in C. albicans in order to identify important genetic modulators of drug resistance, and further expand CRISPRi technology towards genome-wide functional genomic screening platform for antifungal drug sensitivity. Additionally, this research program will develop and optimize two novel platforms: a CRISPR activation (CRISPRa)-based genetic overexpression system, and a targeted CRISPR base editor system for diverse genetic applications in fungal species. Collectively, this CRC research program will apply leading edge CRISPR-based functional genomics to current and emerging fungal pathogens to decipher the genetic mechanisms mediating drug resistance.
Program
Canada Research Chairs
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
CRC-2021-00151
Name nom
Shapiro, Rebecca
Department département
Molecular and Cellular Biology - University of Guelph
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2021
Award amount
120000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Field of research list codes
RDF1060602
Field of research list names en
Developmental genetics (including sex determination)
Field of research list names fr
Génétique du développement (y compris la détermination du sexe)
Socioeconomic objective list codes
RDS10701
Socioeconomic objective list names en
Human health procedures and pharmaceutical treatments
Socioeconomic objective list names fr
Interventions et traitements pharmaceutiques ayant trait à la santé humaine
Application title
Microbial Functional Genomics and Synthetic Biology
Keywords
Fungal genetics; Functional genomics; CRISPR; Antimicrobial resistance; Fungal pathogens
Application summary
Studying the genetic underpinnings of fungal biology and drug resistance has been hindered by genetic limitations associated working with this group of microbes, including its diploid nature, incomplete sexual cycle and atypical codon usage. CRISPR-Cas-based technologies have now revolutionized our ability to perform targeted genome editing in these microorganisms. This CRC research program will develop novel CRISPR-based biotechnologies to establish large-scale genetic libraries for functional analysis in the prevalent fungal pathogen, Candida albicans. Like other fungal infections, C. albicans is notoriously challenging to treat and represents a growing public health concern. This research will exploit a novel CRISPR interference (CRISPRi)-based genetic repression system for comparative functional genomic analysis of drug resistance in C. albicans in order to identify important genetic modulators of drug resistance, and further expand CRISPRi technology towards genome-wide functional genomic screening platform for antifungal drug sensitivity. Additionally, this research program will develop and optimize two novel platforms: a CRISPR activation (CRISPRa)-based genetic overexpression system, and a targeted CRISPR base editor system for diverse genetic applications in fungal species. Collectively, this CRC research program will apply leading edge CRISPR-based functional genomics to current and emerging fungal pathogens to decipher the genetic mechanisms mediating drug resistance.